Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Northrim BanCorp announced a regular quarterly cash dividend of $0.17 per share, payable September 18, 2026, representing a 2.64% annualized yield at the current stock price of $25.80. The company reported strong earnings growth with Q2 2026 net income of $15.3 million ($0.68 per diluted share), up from $13.7 million in Q1 2026 and $11.8 million in Q2 2025.
Monteverde & Associates PC is investigating four major M&A transactions on behalf of shareholders: Northrim Bancorp's merger with PBCO Financial Corporation, Neuphoria Therapeutics' merger with Scancell Holdings plc, Safety Insurance Group's sale to a Mapfre affiliate, and RE/MAX Holdings' sale to The Real Brokerage Inc. The firm encourages shareholders to contact them regarding potential concerns with these deals.
Halper Sadeh LLC, an investor rights law firm, is investigating three companies for potential securities law violations and breaches of fiduciary duties. Utz Brands is being acquired by Intersnack Group for $14.25 per share, BioLife Solutions is being sold to Repligen Corporation for $11.25 per share plus stock consideration, and Northrim BanCorp is merging with PBCO Financial Corporation. The firm is concerned that insiders may receive substantial benefits unavailable to ordinary shareholders and that transaction terms may limit competing offers.
Filed: 2026-07-23 AccNo: 0001163370-26-000027 Size: 4 MB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits